GlassScriptPhysician profile
Alyssa Grkinich
NPI 1396227575
$3,618.71
in general payments reported to CMS, 2019-2025
16 companies · $863 in 2025
The $863 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2021: $409 · 2022: $505 · 2023: $625 · 2024: $1,113 · 2025: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,601.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $897.17 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Bausch & Lomb Americas INC. | $612.82 | 2022-2025 | Infuse, Revive, Miebo |
| Harrow Eye, LLC | $243.56 | 2024-2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $231.51 | 2019-2025 | |
| Kala Pharmaceuticals, INC. | $189.03 | 2021 | |
| Horizon Therapeutics Plc | $187.23 | 2022-2023 | Tepezza |
| Oyster Point Pharma, INC. | $187.17 | 2023 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $176.20 | 2024-2025 | Acthar |
| Biotissue Holdings INC. | $164.10 | 2019-2022 | |
| Dompe US, INC. | $153.71 | 2025 | Oxervate |
| Coopervision INC. | $148.09 | 2022-2024 | Myday Contact Lens |
| Tarsus Pharmaceuticals, INC. | $140.05 | 2024-2025 | Xdemvy |
| Allergan, INC. | $124.93 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $107.07 | 2019-2021 | |
| Abbvie INC. | $35.30 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $20.77 | 2024 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Grkinich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.